PRESTIGENSUMER HEALTHCARE ($PBH) posted quarterly earnings results for Q3 2026 on Thursday, February 5th. The company reported earnings of $1.14 per share, missing estimates of $1.16 by $0.02. The company also reported revenue of $283,440,000, missing estimates of $284,832,120 by $-1,392,120.
You can see Quiver Quantitative's $PBH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PRESTIGENSUMER HEALTHCARE Insider Trading Activity
PRESTIGENSUMER HEALTHCARE insiders have traded $PBH stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $PBH stock by insiders over the last 6 months:
- JEFFREY ZERILLO (Senior VP Operations) has made 0 purchases and 2 sales selling 1,000 shares for an estimated $60,000.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PRESTIGENSUMER HEALTHCARE Hedge Fund Activity
We have seen 172 institutional investors add shares of PRESTIGENSUMER HEALTHCARE stock to their portfolio, and 201 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARIEL INVESTMENTS, LLC added 1,392,632 shares (+63.2%) to their portfolio in Q3 2025, for an estimated $86,900,236
- INVESCO LTD. removed 731,674 shares (-57.4%) from their portfolio in Q3 2025, for an estimated $45,656,457
- NORDEA INVESTMENT MANAGEMENT AB added 520,186 shares (+547.4%) to their portfolio in Q4 2025, for an estimated $32,090,274
- VICTORY CAPITAL MANAGEMENT INC removed 514,733 shares (-86.2%) from their portfolio in Q3 2025, for an estimated $32,119,339
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC added 464,947 shares (+26.6%) to their portfolio in Q3 2025, for an estimated $29,012,692
- GOLDMAN SACHS GROUP INC removed 414,502 shares (-39.3%) from their portfolio in Q3 2025, for an estimated $25,864,924
- BLACKROCK, INC. removed 373,704 shares (-4.7%) from their portfolio in Q3 2025, for an estimated $23,319,129
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PRESTIGENSUMER HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $PBH in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Scotiabank issued a "Sector Outperform" rating on 12/18/2025
- Canaccord Genuity issued a "Buy" rating on 11/07/2025
- RBC Capital issued a "Outperform" rating on 11/04/2025
- Oppenheimer issued a "Outperform" rating on 10/21/2025
To track analyst ratings and price targets for PRESTIGENSUMER HEALTHCARE, check out Quiver Quantitative's $PBH forecast page.
PRESTIGENSUMER HEALTHCARE Price Targets
Multiple analysts have issued price targets for $PBH recently. We have seen 5 analysts offer price targets for $PBH in the last 6 months, with a median target of $88.0.
Here are some recent targets:
- Keith Devas from Jefferies set a target price of $66.0 on 02/02/2026
- Ryland Conrad from RBC Capital set a target price of $132.0 on 12/18/2025
- John Zamparo from Scotiabank set a target price of $120.0 on 12/18/2025
- Susan Anderson from Canaccord Genuity set a target price of $88.0 on 11/07/2025
- Rupesh Parikh from Oppenheimer set a target price of $72.0 on 10/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
